Literature DB >> 12409643

Medulloblastomas with favorable versus unfavorable histology: how many small blue cell tumor types are there in the brain?

Arie Perry1.   

Abstract

Prognostically favorable and unfavorable variants of medulloblastoma have recently been identified, corresponding to medulloblastoma with extensive nodularity and large cell/anaplastic medulloblastoma, respectively. In an effort to identify clinically relevant grading criteria for medulloblastoma in general, 330 Pediatric Oncology Group (POG) cases were carefully reviewed for presence and extent of histologic anaplasia, nodularity, and desmoplasia. The resulting data was statistically analyzed using event-free and overall patient survival as endpoints. Significant anaplasia (moderate to severe) was identified in 24% of cases and was strongly associated with decreased survival times. Additionally, those with diffuse or extensive anaplasia fared worse than those with only focal anaplasia. Although the study confirmed the favorable prognosis for the rare cases of medulloblastoma with extensive nodularity, lesser degrees of nodularity or desmoplasia were not associated with a statistically significant survival advantage. Medulloblastoma grading based on anaplasia demonstrated a statistically stronger association with patient outcome than clinical staging. Therefore, histologic grading of medulloblastomas seems warranted as a routine diagnostic aid.

Entities:  

Mesh:

Year:  2002        PMID: 12409643     DOI: 10.1097/00125480-200211000-00003

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  8 in total

1.  Magnetic resonance imaging spectrum of medulloblastoma.

Authors:  Julia Fruehwald-Pallamar; Stefan B Puchner; Andrea Rossi; Maria L Garre; Armando Cama; Claus Koelblinger; Anne G Osborn; Majda M Thurnher
Journal:  Neuroradiology       Date:  2011-01-29       Impact factor: 2.804

2.  Embryonal central nervous system neoplasms arising in infants and young children: a pediatric brain tumor consortium study.

Authors:  Roger E McLendon; Adesina Adekunle; Veena Rajaram; Mehmet Koçak; Susan M Blaney
Journal:  Arch Pathol Lab Med       Date:  2011-08       Impact factor: 5.534

3.  Morphological and molecular features of astroblastoma, including BRAFV600E mutations, suggest an ontological relationship to other cortical-based gliomas of children and young adults.

Authors:  Norman L Lehman; Eyas M Hattab; Bret C Mobley; Aisulu Usubalieva; Matthew J Schniederjan; Roger E McLendon; Werner Paulus; Elisabeth J Rushing; Maria-Magdalena Georgescu; Marta Couce; Mohanpal S Dulai; Mark L Cohen; Christopher R Pierson; Jack M Raisanen; Sarah E Martin; Trang D Lehman; Eric S Lipp; Jose M Bonnin; Mousa A Al-Abbadi; Kara Kenworthy; Kevin Zhao; Nehad Mohamed; Guojuan Zhang; Weiqiang Zhao
Journal:  Neuro Oncol       Date:  2016-07-14       Impact factor: 12.300

Review 4.  Recent advances in embryonal tumours of the central nervous system.

Authors:  Chitra Sarkar; Prabal Deb; Mehar Chand Sharma
Journal:  Childs Nerv Syst       Date:  2005-01-29       Impact factor: 1.475

5.  A novel role of HLA class I in the pathology of medulloblastoma.

Authors:  Courtney Smith; Mariarita Santi; Bhargavi Rajan; Elisabeth J Rushing; Mi Rim Choi; Brian R Rood; Robert Cornelison; Tobey J MacDonald; Stanislav Vukmanovic
Journal:  J Transl Med       Date:  2009-07-12       Impact factor: 5.531

6.  Early recurrence in standard-risk medulloblastoma patients with the common idic(17)(p11.2) rearrangement.

Authors:  Gabriel A Bien-Willner; Dolores López-Terrada; Meena B Bhattacharjee; Kayuri U Patel; Pawel Stankiewicz; James R Lupski; John D Pfeifer; Arie Perry
Journal:  Neuro Oncol       Date:  2012-05-09       Impact factor: 12.300

Review 7.  Childhood Medulloblastoma: Current Therapies, Emerging Molecular Landscape and Newer Therapeutic Insights.

Authors:  Soumen Khatua; Anne Song; Divyaswathi Citla Sridhar; Stephen C Mack
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

8.  Mutation and expression analysis in medulloblastoma yields prognostic variants and a putative mechanism of disease for i17q tumors.

Authors:  Gabriel A Bien-Willner; Robi D Mitra
Journal:  Acta Neuropathol Commun       Date:  2014-07-17       Impact factor: 7.801

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.